AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors.

Todd M Bauer,Kathleen N Moore,Janet S Rader,Fiona Simpkins,Alain C Mita,J Thaddeus Beck,Lowell Hart,Quincy Chu,Amit Oza,Anna V Tinker,Esteban Rodrigo Imedio,Sanjeev Kumar,Ganesh Mugundu,Suzanne Jenkins,Juliann Chmielecki,Suzanne Jones,David Spigel,Siqing Fu

Targeted oncology（2023）

引用 1|浏览26
暂无评分
摘要
ClinicalTrials.gov identifier NCT02482311; registered June 2015.
更多
查看译文
关键词
inhibitor,monotherapy,solid tumors,first-in-class
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要